Stocks and Investing Stocks and Investing
Wed, December 22, 2021
[ 12:00 AM ] - WOPRAI
Jay Olson Maintained (BIIB) at Buy with Decreased Target to $350 on, Dec 22nd, 2021
[ 12:00 AM ] - WOPRAI
Chad Dillard Downgraded (AGCO) to Hold and Decreased Target to $127 on, Dec 22nd, 2021
[ 12:00 AM ] - WOPRAI
David Koning Maintained (ACN) at Hold and Held Target at $410 on, Dec 22nd, 2021
[ 12:00 AM ] - WOPRAI
Jayson Bedford Maintained (ABT) at Buy with Increased Target to $150 on, Dec 22nd, 2021
[ 12:00 AM ] - WOPRAI
Sumant Kulkarni Maintained (ACAD) at Hold with Increased Target to $30 on, Dec 22nd, 2021
[ 12:00 AM ] - WOPRAI
Jim Suva Maintained (AAPL) at Strong Buy with Increased Target to $200 on, Dec 22nd, 2021
[ 12:00 AM ] - WOPRAI
Gabe Hajde Maintained (ATR) at Buy with Decreased Target to $156 on, Dec 22nd, 2021
[ 12:00 AM ] - WOPRAI
Chad Dillard Upgraded (CAT) to Buy and Held Target at $240 on, Dec 22nd, 2021
[ 12:00 AM ] - WOPRAI
Michael Yee Downgraded (ALXO) to Hold and Decreased Target to $25 on, Dec 22nd, 2021
[ 12:00 AM ] - WOPRAI
Carter Gould Maintained (ALLK) at Sell with Decreased Target to $8 on, Dec 22nd, 2021
[ 12:00 AM ] - WOPRAI
Tim Lugo Downgraded (ALLK) to Hold on, Dec 22nd, 2021
[ 12:00 AM ] - WOPRAI
Thomas Smith Downgraded (ALLK) to Hold and Decreased Target to $17 on, Dec 22nd, 2021
[ 12:00 AM ] - WOPRAI
Joseph Moore Downgraded (ALLK) to Hold on, Dec 22nd, 2021
[ 12:00 AM ] - WOPRAI
Maury Raycroft Downgraded (ALLK) to Hold on, Dec 22nd, 2021
Tue, December 21, 2021
[ 12:00 AM ] - WOPRAI
Kennen MacKay Maintained (AMGN) at Hold with Increased Target to $218 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Steve Valiquette Maintained (AMED) at Buy with Decreased Target to $213 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Sergio Matsumoto Maintained (AVO) at Hold with Decreased Target to $20 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Jason Mollin Downgraded (AVAL) to Hold and Held Target at $6.2 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Philip Gibbs Maintained (ATI) at Buy with Decreased Target to $21 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (ATO) at Buy with Increased Target to $126 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
James Cordwell Downgraded (BABA) to Hold and Decreased Target to $140 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
John Lawrence Initiated (BOOT) at Strong Buy and Held Target at $135 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Robert Burns Maintained (BNTX) at Strong Buy with Increased Target to $366 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
C. Gregory Peters Maintained (BRO) at Buy with Increased Target to $75 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Richard Newitter Maintained (BSX) at Strong Buy with Increased Target to $53 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Patrick Walravens Maintained (BRZE) at Buy with Increased Target to $90 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
George Tong Maintained (BV) at Hold with Decreased Target to $15 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Richard Newitter Maintained (ZBH) at Strong Buy with Decreased Target to $145 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Sean Eastman Maintained (ABM) at Buy with Decreased Target to $55 on, Dec 21st, 2021
[ 12:00 AM ] - WOPRAI
Robert Wasserman Initiated (ABCL) at Strong Buy and Held Target at $27 on, Dec 21st, 2021

Robert Wasserman Initiated (ABCL) at Strong Buy and Held Target at $27 on, Dec 21st, 2021


Published on 2024-10-27 19:04:20 - WOPRAI, Robert Wasserman
  Print publication without navigation


Robert Wasserman of Benchmark, Initiated "AbCellera Biologics Inc." (ABCL) at Strong Buy and Held Target at $27 on, Dec 21st, 2021.

Robert has made no other calls on ABCL in the last 4 months.



There is 1 other peer that has a rating on ABCL. Out of the 1 peers that are also analyzing ABCL, 0 agree with Robert's Rating of Hold.



This is the rating of the analyst that currently disagrees with Robert

  • Do Kim of "Piper Sandler" Initiated at Buy and Held Target at $33 on, Friday, November 19th, 2021
Contributing Sources